Acute reversible central nervous system toxicity associated with low-dose oral cyclosporine therapy
- 30 September 1993
- journal article
- case report
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 29 (3) , 490-492
- https://doi.org/10.1016/s0190-9622(08)82005-1
Abstract
No abstract availableThis publication has 41 references indexed in Scilit:
- Treatment of pyoderma gangrenosum with cyclosporine: Results in seven patientsJournal of the American Academy of Dermatology, 1991
- Cyclosporine treatment of pyoderma gangrenosumJournal of the American Academy of Dermatology, 1991
- Cyclosporine in nonpsoriatic dermatosesJournal of the American Academy of Dermatology, 1990
- Management of patients and side effects during cyclosporine therapy for cutaneous disordersJournal of the American Academy of Dermatology, 1990
- Cyclosporine in dermatologyJournal of the American Academy of Dermatology, 1989
- Treatment of recalcitrant pyoderma gangrenosum with cyclosporineJournal of the American Academy of Dermatology, 1989
- Cyclosporine therapy for pyoderma gangrenosum associated with sclerosing cholangitis and ulcerative colitisJournal of the American Academy of Dermatology, 1988
- NEUROLOGICAL COMPLICATIONS FOLLOWING LIVER TRANSPLANTATIONThe Lancet, 1987
- Complications of cyclosporin therapyWorld Journal of Surgery, 1986
- Cyclosporine-Associated Central-Nervous-System Toxicity after Allogeneic Bone-Marrow TransplantationNew England Journal of Medicine, 1984